Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP814558.RAK-PbPOCqy567VQIm76u59nO-_aD3ax0hRVQ2Oq_zeFM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP814558.RAK-PbPOCqy567VQIm76u59nO-_aD3ax0hRVQ2Oq_zeFM130_assertion type Assertion NP814558.RAK-PbPOCqy567VQIm76u59nO-_aD3ax0hRVQ2Oq_zeFM130_head.
- NP814558.RAK-PbPOCqy567VQIm76u59nO-_aD3ax0hRVQ2Oq_zeFM130_assertion description "[Furthermore, we found that L1, ezrin and phosphorylated p65 are co-expressed at the invasive front in human CRC tissue, indicating that L1-mediated activation of NF-kappaB signaling involving ezrin is a major route of CRC progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP814558.RAK-PbPOCqy567VQIm76u59nO-_aD3ax0hRVQ2Oq_zeFM130_provenance.
- NP814558.RAK-PbPOCqy567VQIm76u59nO-_aD3ax0hRVQ2Oq_zeFM130_assertion evidence source_evidence_literature NP814558.RAK-PbPOCqy567VQIm76u59nO-_aD3ax0hRVQ2Oq_zeFM130_provenance.
- NP814558.RAK-PbPOCqy567VQIm76u59nO-_aD3ax0hRVQ2Oq_zeFM130_assertion SIO_000772 20501702 NP814558.RAK-PbPOCqy567VQIm76u59nO-_aD3ax0hRVQ2Oq_zeFM130_provenance.
- NP814558.RAK-PbPOCqy567VQIm76u59nO-_aD3ax0hRVQ2Oq_zeFM130_assertion wasDerivedFrom befree-2016 NP814558.RAK-PbPOCqy567VQIm76u59nO-_aD3ax0hRVQ2Oq_zeFM130_provenance.
- NP814558.RAK-PbPOCqy567VQIm76u59nO-_aD3ax0hRVQ2Oq_zeFM130_assertion wasGeneratedBy ECO_0000203 NP814558.RAK-PbPOCqy567VQIm76u59nO-_aD3ax0hRVQ2Oq_zeFM130_provenance.